APA (7th ed.) Citation

Baranašić, J., Šutić, M., Catalano, C., Drpa, G., Huhn, S., Majhen, D., . . . Knežević, J. (2022). TLR5 variants are associated with the risk for COPD and NSCLC development, better overall survival of the NSCLC patients and increased chemosensitivity in the H1299 cell line. Biomedicines, 10(9), . https://doi.org/10.3390/biomedicines10092240

Chicago Style (17th ed.) Citation

Baranašić, Jurica, et al. "TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line." Biomedicines 10, no. 9 (2022). https://doi.org/10.3390/biomedicines10092240.

MLA (9th ed.) Citation

Baranašić, Jurica, et al. "TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line." Biomedicines, vol. 10, no. 9, 2022, https://doi.org/10.3390/biomedicines10092240.